Herbicide: Fatal Ammonium Thiocyanate and Aminotriazole Poisoning

References

• Nichols J. B. The pharmacologic and therapeutic properties of the sulfocyanates. Am J Med Sci 1925; 170: 735–747
   Google Scholar
• Cohn J. N., Burke L. P. Nitroprusside. Ann Intern Med 1979; 91: 752–757
   PubMed Web of Science ®Google Scholar
• Palmer R. F., Lasseter K. C. Drug therapy. Sodium nitroprusside. N Engl J Med 1975; 292: 294–297
   PubMed Web of Science ®Google Scholar
• Rudd P., Blaschke F. Antihypertensive agents and the drug therapy of hypertension. Goodman and Gilman 's The Pharmacological Basis of Therapeutics7th ed., A. Goodman Gilman, L. S. Goodman, T. W. Rail, et al. MacMillan Publishing Company, New York, NY 1985; 784–805
   Google Scholar
• Schulz V., Dohring V., Rathsack P. ‘Thiocyanate poisoning in antihypertensive therapy using sodium nitroprusside’. Wein Med Wochenschr 1978; 128: 434–435
   PubMedGoogle Scholar
• Bowler R. G. Determination of thiocyanate in blood serum. Biochem J 1944; 38: 385–388
   PubMedGoogle Scholar
• Wang T., Diamandis E. P., Lane A., Baines A. D. Variable selectivity of the Hitachi chemistry analyzer chloride ion-selective electrode toward interfering ions. Clin Biochem 1994; 27: 37–41
   PubMed Web of Science ®Google Scholar
• IPCS. Environmental Health Criteria 158: Amitrole. World Health Organization, Geneva 1994
   Google Scholar
• Gaines T. B., Kimbrough R. D., Linder R. E. The toxicity of amitrole in the rat. Toxicol Appl Pharmacol 1973; 26: 118–129
   PubMed Web of Science ®Google Scholar
• Alexander N. M. Antithyroid action of 3-amino- 1,2, 4-triazole. J Biol Chem 1959; 234: 148–150
   PubMed Web of Science ®Google Scholar
• Helm W. G., Appleman D., Pyfrom H. T. Effects of 3-amino-l,2,4-triazole on catalase and other compounds. Am J Physiol 1956; 86: 19–23
   Google Scholar
• Balkisson R., Murray D., Hoffstein V. Alveolar damage due to inhalation of amitrole-containing herbicide. Chest 1992; 101: 1174–1176
   PubMed Web of Science ®Google Scholar
• Pommery J., Mathieu M., Mathieu D., Lhermitte M. Atrazine in plasma and tissue following atrazine-aminotriazole-ethyleneglycol-formaldehydepoisoning. J Toxicol Clin Toxicol 1993; 31: 323–331
   PubMed Web of Science ®Google Scholar
• von Mallinckrodt M. G., Schmidt H. P. ‘Toxicity and metabolism of aminotriazole in man’. Arch Toxikol 1970; 27: 13–18
   PubMedGoogle Scholar
• Garvin C. F. The fatal toxic manifestations of the thiocyanates. JAMA 1939; 112: 1125–1127
   Google Scholar
• Gorman W. F., Messinger E., Herman M. Toxicity of thiocyanates used in treatment of hypertension. Ann Intern Med 1949; 30: 1054–1059
   PubMed Web of Science ®Google Scholar
• Russel W. O., Stahl W. C. Fatal poisoning from potassium thiocyanate treatment of hypertension. JAMA 1942; 119: 1177–1181
   Google Scholar
• Solomon J., Greenblatt M., Coon G. P. Toxic psychosis and death associated with potassium thiocyanate therapy. N Engl J Med 1943; 229: 241–243
   Google Scholar
• Waid M. H., Lindberg H. A., Barker M. H. The toxic manifestations of the thiocyanates. JAMA 1939; 112: 1120–1124
   Google Scholar
• Christensen J., Wiliams B. J. Thiocyanate psychosis treated by extracorporeal hemodialysis. JAMA 1962; 181: 340–342
   PubMed Web of Science ®Google Scholar
• Schulz V., Bonn R., Kindler J. Kinetics of elimination of thiocyanate in 7 healthy subjects and in 8 subjects with renal failure. Klin Wochenschr 1979; 57: 243–247
   PubMedGoogle Scholar
• Pines K. L., Crumble M. In vitro conversion of thiocyanate to cyanide in the presence of erythrocytes. Proc Soc Exp Biol Med 1952; 81: 160–163
   PubMed Web of Science ®Google Scholar
• Goldstein F., Rieders F. Formation of cyanide in dog and man following administration of thiocyanate. Am J Physiol 1951; 167: 47–51
   PubMed Web of Science ®Google Scholar
• Chung J., Wood J. L. Oxidation of thiocyanate to cyanide catalyzed by hemoglobin. J Biol Chem 1971; 246: 555–560
   PubMed Web of Science ®Google Scholar
• Yeoman W. B. Metals and anions, thiocyanate. Clarke's Isolation and Identification of Drugs in Pharmaceutical, Body Fluids, and Post-Mortem Material2nd ed., A. C. Moffat, J. V. Jackson, M. S. Moss, B. Widdop. The Pharmaceutical Press, London 1986; 68–69
   Google Scholar
• Barker M. H. The blood cyanates in the treatment of hypertension. JAMA 1936; 106: 762–767
   Google Scholar
• Danzig L. E. Dynamics of thiocyanate dialysis. The artificial kidney in the therapy of thiocyanate intoxication. N Engl J Med 1955; 252: 49–57
   PubMed Web of Science ®Google Scholar
• Domzalski C. A., Kolb L. C., Hines E. A. Delirious reactions secondary to thiocyanate therapy of hypertension. Proc Mayo Clin 1953; 28: 272–280
   PubMed Web of Science ®Google Scholar
• Nickerson M., Thomas J. J. Renal excretion of thiocyanate. J Lab Clin Med 1951; 38: 194–198
   PubMed Web of Science ®Google Scholar
• Walser M., Rahill W. J. Nitrate, thiocyanate, and perchlorate clearance in relation to chloride clearance. Am J Physiol 1965; 208: 1158–1164
   PubMed Web of Science ®Google Scholar